Literature DB >> 18511880

Forced expression of HoxB4 enhances hematopoietic differentiation by human embryonic stem cells.

Gab Sang Lee1, Byung Soo Kim, Jae-Hung Sheih, Malcolm Moore.   

Abstract

HoxB4 has been shown to enhance hematopoietic engraftment by hematopoietic stem cells (HSC) from differentiating mouse embryonic stem cell (mESC) cultures. Here we examined the effect of ectopic expression of HoxB4 in differentiated human embryonic stem cells (hESCs). Stable HoxB4-expressing hESCs were established by lentiviral transduction, and the forced expression of HoxB4 did not affect stem cell features. HoxB4-expressing hESC-derived CD34+ cells generated higher numbers of erythroid and blast-like colonies than controls. The number of CD34+ cells increased but CD45+ and KDR+ cell numbers were not significantly affected. When the hESC derived CD34+ cells were transplanted into NOD/SCID beta 2m-/- mice, the ectopic expression of HoxB4 did not alter their repopulating capacity. Our findings show that overexpression of HoxB4 in differentiating hESCs increases hematopoietic colony formation and hematopoietic cell formation in vitro, but does not affect in vivo repopulation in adult mice hosts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18511880

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  15 in total

Review 1.  Hematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells.

Authors:  Igor I Slukvin
Journal:  Blood       Date:  2013-10-11       Impact factor: 22.113

Review 2.  Progress and obstacles towards generating hematopoietic stem cells from pluripotent stem cells.

Authors:  Jungmin Lee; Brad Dykstra; Robert Sackstein; Derrick J Rossi
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

Review 3.  Making HSCs in vitro: don't forget the hemogenic endothelium.

Authors:  Bradley W Blaser; Leonard I Zon
Journal:  Blood       Date:  2018-08-08       Impact factor: 22.113

4.  Hoxc8 downregulates Mgl1 tumor suppressor gene expression and reduces its concomitant function on cell adhesion.

Authors:  Kalyani Ruthala; Jogeswar Gadi; Ji-Yeon Lee; Heejei Yoon; Hyun Joo Chung; Myoung Hee Kim
Journal:  Mol Cells       Date:  2011-07-15       Impact factor: 5.034

Review 5.  De novo generation of HSCs from somatic and pluripotent stem cell sources.

Authors:  Linda T Vo; George Q Daley
Journal:  Blood       Date:  2015-03-11       Impact factor: 22.113

6.  Generation of CD34+ cells from human embryonic stem cells using a clinically applicable methodology and engraftment in the fetal sheep model.

Authors:  Jaehyup Kim; Esmail D Zanjani; Christine M Jeanblanc; A Daisy Goodrich; Peiman Hematti
Journal:  Exp Hematol       Date:  2013-04-20       Impact factor: 3.084

Review 7.  Running the full human developmental clock in interspecies chimeras using alternative human stem cells with expanded embryonic potential.

Authors:  Justin Thomas; Ludovic Zimmerlin; Jeffrey S Huo; Michael Considine; Leslie Cope; Elias T Zambidis
Journal:  NPJ Regen Med       Date:  2021-05-17

8.  Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

Authors:  Gabsang Lee; Eirini P Papapetrou; Hyesoo Kim; Stuart M Chambers; Mark J Tomishima; Christopher A Fasano; Yosif M Ganat; Jayanthi Menon; Fumiko Shimizu; Agnes Viale; Viviane Tabar; Michel Sadelain; Lorenz Studer
Journal:  Nature       Date:  2009-08-19       Impact factor: 49.962

9.  Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors.

Authors:  Sergei Doulatov; Linda T Vo; Stephanie S Chou; Peter G Kim; Natasha Arora; Hu Li; Brandon K Hadland; Irwin D Bernstein; James J Collins; Leonard I Zon; George Q Daley
Journal:  Cell Stem Cell       Date:  2013-10-03       Impact factor: 24.633

10.  A robust strategy for negative selection of Cre-loxP recombination-based excision of transgenes in induced pluripotent stem cells.

Authors:  Syandan Chakraborty; Nicolas Christoforou; Ali Fattahi; Roland W Herzog; Kam W Leong
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.